ReadYourDNA

Simvastatin (Zocor)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Simvastatin

What it is

Simvastatin is a statin: it blocks HMG-CoA reductase, the liver enzyme that makes cholesterol, so the liver takes more LDL cholesterol out of the blood. It is used to lower cholesterol and to reduce the chance of heart attack and stroke. It is sold as Zocor, among other names.

How genes come into it

Simvastatin has the strongest link of all statins to SLCO1B1, the gene for a transporter that carries statins into the liver. The common variant rs4149056 (in the *5 and *15 versions) weakens the transporter, so more simvastatin stays in the blood. In the large SEARCH study, people with two copies had many times the rate of muscle damage on a high dose. CPIC and DPWG have published guidelines on SLCO1B1 and simvastatin, and the US FDA lists it as affecting safety. Studies have also looked at CYP3A4 and CYP3A5, which break simvastatin down, and at genes linked to how much cholesterol falls, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Simvastatin. They sort people into groups by the gene copies they carry.

CPIC guideline: SLCO1B1. Normal Function · Poor Function · Increased Function · Decreased Function · Possible Decreased Function · Indeterminate. Strong. 2022.

DPWG guideline: SLCO1B1. Normal Function · Poor Function · Increased Function · Decreased Function · Possible Decreased Function · Indeterminate. 2024.

US FDA: SLCO1B1. Poor Function · Decreased Function · Possible Decreased Function. Data that Indicate a Potential Impact on Safety or Response.

What research found

Every published finding on gene variants and Simvastatin. Upload your DNA file to see which of these rows apply to you.

Rated evidence (55 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15: Level 1A · replicated. Toxicity: statin-related myopathy. 14.

SLCO1B1 rs4149056: Level 1A · replicated. Toxicity: statin-related myopathy. 9.

SLCO1B1 rs4149056: Level 1A · replicated. Metabolism/PK. 9.

SLCO1B1 SLCO1B1*1, SLCO1B1*5, SLCO1B1*15: Level 1A · replicated. Metabolism/PK. 9.

Metabolism (14 findings)

Studies of how quickly the body processes this medication.

CYP2D6 CYP2D6*1, CYP2D6*14: CYP2D6 *14 is associated with increased concentrations of simvastatin in healthy individuals as compared to CYP2D6 *1/*1.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *1/*22 is associated with increased concentrations of simvastatin in people with Hypercholesterolemia as compared to CYP3A4 *1/*1.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.

CYP3A4 CYP3A4*1, CYP3A4*22: CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.

Response (70 findings)

Studies of how well it worked in people carrying a variant.

ABCA1 rs12003906: Allele C is associated with decreased response to atorvastatin, pravastatin or simvastatin in people with Hyperlipidemias as compared to allele G.

ABCA1 rs2230806: Allele T is associated with decreased response to atorvastatin, rosuvastatin or simvastatin as compared to allele C.

ABCA1 rs769705621: Allele AAAA is associated with decreased response to atorvastatin, rosuvastatin or simvastatin in people with familial hypercholesterolemia as compared to genotypes A/AA + A/del.

ABCB1 rs1128503: Genotype GG is associated with decreased response to simvastatin in people with Hypercholesterolemia as compared to genotypes AA + AG.

Dosing (2 findings)

Studies of how much of the drug people needed or tolerated.

CYP2C9 CYP2C9*1, CYP2C9*3: CYP2C9 *3 is associated with decreased dose of warfarin when treated with simvastatin and warfarin.

CYP2C9 CYP2C9*1, CYP2C9*2: CYP2C9 *2 is not associated with decreased dose of warfarin when treated with simvastatin and warfarin.

Other findings (1 finding)

Studies that do not fall into the groups above.

APOA5 rs662799: Genotype AA is associated with response to atorvastatin, rosuvastatin and simvastatin in people with Dyslipidaemia as compared to genotypes AG + GG.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Baycol (Statins)

Crestor (Statins)

Lescol (Statins)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com